These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 2116226)

  • 41. Studies in mice treated with ICRF-159 combined with daunorubicin or doxorubicin.
    Giuliani F; Casazza AM; Di Marco A; Savi G
    Cancer Treat Rep; 1981; 65(3-4):267-76. PubMed ID: 6263470
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protective effect of Spirulina against doxorubicin-induced cardiotoxicity.
    Khan M; Shobha JC; Mohan IK; Naidu MU; Sundaram C; Singh S; Kuppusamy P; Kutala VK
    Phytother Res; 2005 Dec; 19(12):1030-7. PubMed ID: 16372368
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of pyrrolidine dithiocarbamate on antioxidant enzymes in cardiomyopathy induced by adriamycin in rats.
    Mingyan E; Hongli L; Shufeng L; Bo Y
    Cardiology; 2008; 111(2):119-25. PubMed ID: 18376123
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cytoprotective agents for anthracyclines.
    Dorr RT
    Semin Oncol; 1996 Aug; 23(4 Suppl 8):23-34. PubMed ID: 8783663
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Protective effects of Terminalia arjuna against Doxorubicin-induced cardiotoxicity.
    Singh G; Singh AT; Abraham A; Bhat B; Mukherjee A; Verma R; Agarwal SK; Jha S; Mukherjee R; Burman AC
    J Ethnopharmacol; 2008 Apr; 117(1):123-9. PubMed ID: 18346858
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Doxorubicin-induced cardiotoxicity monitored by ECG in freely moving mice. A new model to test potential protectors.
    van Acker SA; Kramer K; Voest EE; Grimbergen JA; Zhang J; van der Vijgh WJ; Bast A
    Cancer Chemother Pharmacol; 1996; 38(1):95-101. PubMed ID: 8603459
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of ICRF-187 on doxorubicin-induced myocardial effects in the mouse and guinea pig.
    Perkins WE; Schroeder RL; Carrano RA; Imondi AR
    Br J Cancer; 1982 Oct; 46(4):662-7. PubMed ID: 6814473
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of ICRF 159 on adriamycin-induced cardiomyopathy in rats.
    Decorti G; Bartoli Klugmann F; Mallardi F; Klugmann S; Benussi B; Grill V; Baldini L
    Cancer Lett; 1983 May; 19(1):77-83. PubMed ID: 6406045
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The nitroxide tempol has similar antioxidant effects as physiological levels of 17beta-oestradiol in reversing ovariectomy-induced oxidative stress in mice liver and kidney.
    Enli Y; Oztekin O; Pinarbasili RD
    Scand J Clin Lab Invest; 2009; 69(4):526-34. PubMed ID: 19343575
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of different iron chelators as protective agents against acute doxorubicin-induced cardiotoxicity.
    Voest EE; van Acker SA; van der Vijgh WJ; van Asbeck BS; Bast A
    J Mol Cell Cardiol; 1994 Sep; 26(9):1179-85. PubMed ID: 7815460
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Potentiation of doxorubicin cytotoxicity by (+)-1,2-bis-(3,5-dioxopiperazinyl-1-yl) propane (ICRF-187) in human leukemic HL-60 cells.
    Monti E; Sinha BK
    Cancer Commun; 1990; 2(4):145-9. PubMed ID: 2164412
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Manganese superoxide dismutase protects mitochondrial complex I against adriamycin-induced cardiomyopathy in transgenic mice.
    Yen HC; Oberley TD; Gairola CG; Szweda LI; St Clair DK
    Arch Biochem Biophys; 1999 Feb; 362(1):59-66. PubMed ID: 9917329
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of piperine on antioxidant pathways in tissues from normal and streptozotocin-induced diabetic rats.
    Rauscher FM; Sanders RA; Watkins JB
    J Biochem Mol Toxicol; 2000; 14(6):329-34. PubMed ID: 11083086
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reduction of chronic doxorubicin cardiotoxicity in beagle dogs by bis-morpholinomethyl derivative of razoxane (ICRF-159).
    Herman EH; Ferrans VJ; Bhat HB; Witiak DT
    Cancer Chemother Pharmacol; 1987; 19(4):277-81. PubMed ID: 3594714
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Potential hepatoprotective effects of fullerenol C60(OH)24 in doxorubicin-induced hepatotoxicity in rats with mammary carcinomas.
    Injac R; Perse M; Obermajer N; Djordjevic-Milic V; Prijatelj M; Djordjevic A; Cerar A; Strukelj B
    Biomaterials; 2008; 29(24-25):3451-60. PubMed ID: 18501960
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oxidative damage during chagasic cardiomyopathy development: role of mitochondrial oxidant release and inefficient antioxidant defense.
    Wen JJ; Vyatkina G; Garg N
    Free Radic Biol Med; 2004 Dec; 37(11):1821-33. PubMed ID: 15528041
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Doxorubicin cardiotoxicity and serum lipid increase is prevented by dextrazoxane (ICRF-187).
    Samelis GF; Stathopoulos GP; Kotsarelis D; Dontas I; Frangia C; Karayannacos PE
    Anticancer Res; 1998; 18(5A):3305-9. PubMed ID: 9858900
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardioprotective effect of lipistat against doxorubicin induced myocardial toxicity in albino rats.
    Koti BC; Vishwanathswamy AH; Wagawade J; Thippeswamy AH
    Indian J Exp Biol; 2009 Jan; 47(1):41-6. PubMed ID: 19317350
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The profound effects of microcystin on cardiac antioxidant enzymes, mitochondrial function and cardiac toxicity in rat.
    Qiu T; Xie P; Liu Y; Li G; Xiong Q; Hao L; Li H
    Toxicology; 2009 Mar; 257(1-2):86-94. PubMed ID: 19135122
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of the protective effects against chronic doxorubicin cardiotoxicity and the rates of iron (III) displacement reactions of ICRF-187 and other bisdiketopiperazines.
    Herman EH; Zhang J; Hasinoff BB; Chadwick DP; Clark JR; Ferrans VJ
    Cancer Chemother Pharmacol; 1997; 40(5):400-8. PubMed ID: 9272116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.